ImmuPharma had a revenue of 0.00 in the quarter ending Jun 30, 2024, with ―. This bring the company's revenue in the last twelve months to -69.96K, Increased -6995900.00%. In the fiscal year ending Dec 31, 2023, ImmuPharma had annual revenue of 0.00 with ― growth.